PATENTS RELATED TO COCAINE

Professor Demchick's Patent Services

Paul H. Demchick, United States Registered Patent Agent
(United States Patent and Trademark Office Registration 52,808)

PATENTS RELATED TO COCAINE

Although Dr. Demchick also represents patent seekers with non-biological inventions, his doctorate is in biology. Biology has been the primary focus of his research and teaching. He especially loves dealing with patent searches and applications for involving biology.

Dr. Demchick is a scientist with a quarter of a century of research experience in academic, industrial and governmental settings.
If you are considering patent protection for an invention, Dr. Demchick will be glad to discuss the matter with you. There is no charge for an initial discussion.
The following sampling is to give you some sense of the types of cocaine related inventions which have received United States patent protection. The patent list is not exhaustive and is certainly not a substitute for a proper patent search . It should be noted that only U.S. Patents are included.
It should be noted that spelling, form and typographical errors in the original patents are preserved here.

Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the same, and crack cocaine conjugates (United States Patent 7,105,643)
Cocaine receptor binding ligands (United States Patent 7,011,813)
Anti-cocaine catalytic antibody (United States Patent 6,913,917)
Analogs of cocaine (United States Patent 6,806,281)
Pramipexole as a treatment for cocaine craving (United States Patent 6,750,235)
Cocaine receptor binding ligands (United States Patent 6,706,880)
Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants (United States Patent 6,566,400)
Catalytic antibodies against cocaine and methods of using and producing same (United States Patent 6,566,084)
Cocaine receptor binding ligands (United States Patent 6,531,483)
Analogs of cocaine (United States Patent 6,472,422)
Anti-cocaine vaccine (United States Patent 6,383,490)
Methods for treating psychosis associated with cocaine addiction with glucocorticoid receptor antagonists (United States Patent 6,362,173)
Cocaine receptor binding ligands (United States Patent 6,329,520)
Anti-cocaine catalytic antibody (United States Patent 6,280,987)
Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody (United States Patent 6,271,381)
Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants (United States Patent 6,194,459)
Catalytic antibodies against cocaine and methods of using and producing same (United States Patent 6,184,013)
Analogs of cocaine (United States Patent 6,180,648)
Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody (United States Patent 6,174,723)
Process and test kit for cocaine detection (United States Patent 6,133,040)
Method for making cocaine receptor binding ligands and intermediates therefor (United States Patent 6,123,917)
Immunogens for the production of cocaine-hydrolyzing catalytic antibodies (United States Patent 6,017,541)
Catalytic antibodies against cocaine (United States Patent 5,990,285)
Catalytic antibodies against cocaine (United States Patent 5,977,314)
Anti-cocaine catalytic antibody (United States Patent 5,948,658)
Methods for controlling invertebrate pests using cocaine receptor binding ligands (United States Patent 5,935,953)
Labeled cocaine analogs (United States Patent 5,888,475)
Low dosage treatment for cocaine craving and withdrawal (United States Patent 5,869,474)
Labeled cocaine analogs (United States Patent 5,864,038)
Cocaine analogs (United States Patent 5,834,484)
Compounds for treating cocaine abuse (United States Patent 5,821,386)
4' and 4', 4"-substituted-3-.alpha.-(diphenylmethoxy) tropane analogs as cocaine therapeutics (United States Patent 5,792,775)
Method for treating cocaine and amphetamine dependency (United States Patent 5,760,044)
Reagent for the identification of cocaine (United States Patent 5,753,513)
Cocaine receptor binding ligands (United States Patent 5,736,123)
Immunogens for the production of cocaine-hydrolyzing catalytic antibodies (United States Patent 5,730,985)
Labelling colors for detecting cocaine or methamphetamine, method of preparing the same and detector for cocaine or methamphetamine (United States Patent 5,571,727)
Cocaine analogues and their use as cocaine drug therapies and therapeutic and imaging agents for neurodegenerative disorders (United States Patent 5,506,359)
Cocaine receptor binding ligands (United States Patent 5,496,953)
Reagents for generating a polyclonal hydrolytic antibody response against cocaine and the monoclonal hydrolytic antibodies against cocaine derived through these reagents (United States Patent 5,463,028)
Cocaine esterase from Pseudomonas sp. NCIMB 40427 for detection of cocaine (United States Patent 5,462,868)
Therapeutics for management of cocaine induced toxicity (United States Patent 5,441,982)
Cocaine receptor binding ligands (United States Patent 5,413,779)
Use of delta opioid receptor antagonists to treat cocaine abuse (United States Patent 5,411,965)
Cocaine analogs (United States Patent 5,391,744)
Cocaine receptor binding ligands (United States Patent 5,380,848)
Cocaine analogs (United States Patent 5,268,480)
Cocaine derivatives (United States Patent 5,233,042)
Treatment for cocaine abuse (United States Patent 5,229,120)
Cocaine and cocaine metabolites assay tracers, immunogens and antibodies (United States Patent 5,202,270)
5-aminocarbonyl-5H-dibenzo[a.d]cyclohepten-5,10-imines for treatment of epilepsy and cocaine addiction (United States Patent 5,196,415)
Treatment of cocaine addiction (United States Patent 5,189,064)
Use of sigma receptor antagonists for treatment of cocaine abuse (United States Patent 5,180,729)
Cocaine receptor binding ligands (United States Patent 5,128,118)
Use of calcium channel blocker to prevent cocaine induced craving and reinforcement (United States Patent 5,124,340)
Treatment for cocaine use employing valproic acid (United States Patent 5,102,913)
Treatment for cocaine abuse (United States Patent 5,075,341)
Treatment for cocaine use (United States Patent 5,028,611)
Treatment for cocaine addiction (United States Patent 4,942,182)
Rapid method for interrupting the cocaine and amphetamine abuse syndrome (United States Patent 4,587,243)
Paper device for rapid detection of cocaine (United States Patent 4,320,086)
Available aroma of cocaine (United States Patent 4,260,517)
Simultaneous radio immunoassay of multiple antigens and _assay for cocaine metabolites (United States Patent 4,235,864)
Simultaneous immunoassay of multiple antigens and assay for cocaine metabolites (United States Patent 4,207,307)
Non-oxo-carbonyl containing benzoyl ecgonine and cocaine compounds and derivatives thereof (United States Patent 4,123,431)
Non-oxo-carbonyl containing benzoyl ecgonine and cocaine compounds polypeptide and derivatives thereof (United States Patent 4,045,420)
Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the same, and crack cocaine conjugates (United States Patent 7,105,643)
Cocaine receptor binding ligands (United States Patent 7,011,813)
Anti-cocaine catalytic antibody (United States Patent 6,913,917)
Analogs of cocaine (United States Patent 6,806,281)
Pramipexole as a treatment for cocaine craving (United States Patent 6,750,235)
Cocaine receptor binding ligands (United States Patent 6,706,880)
Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants (United States Patent 6,566,400)
Catalytic antibodies against cocaine and methods of using and producing same (United States Patent 6,566,084)
Cocaine receptor binding ligands (United States Patent 6,531,483)
Analogs of cocaine (United States Patent 6,472,422)
Anti-cocaine vaccine (United States Patent 6,383,490)
Methods for treating psychosis associated with cocaine addiction with glucocorticoid receptor antagonists (United States Patent 6,362,173)
Cocaine receptor binding ligands (United States Patent 6,329,520)
Anti-cocaine catalytic antibody (United States Patent 6,280,987)
Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody (United States Patent 6,271,381)
Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants (United States Patent 6,194,459)
Catalytic antibodies against cocaine and methods of using and producing same (United States Patent 6,184,013)
Analogs of cocaine (United States Patent 6,180,648)
Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody (United States Patent 6,174,723)
Process and test kit for cocaine detection (United States Patent 6,133,040)
Method for making cocaine receptor binding ligands and intermediates therefor (United States Patent 6,123,917)
Immunogens for the production of cocaine-hydrolyzing catalytic antibodies (United States Patent 6,017,541)
Catalytic antibodies against cocaine (United States Patent 5,990,285)
Catalytic antibodies against cocaine (United States Patent 5,977,314)
Anti-cocaine catalytic antibody (United States Patent 5,948,658)
Methods for controlling invertebrate pests using cocaine receptor binding ligands (United States Patent 5,935,953)
Labeled cocaine analogs (United States Patent 5,888,475)
Low dosage treatment for cocaine craving and withdrawal (United States Patent 5,869,474)
Labeled cocaine analogs (United States Patent 5,864,038)
Cocaine analogs (United States Patent 5,834,484)
Compounds for treating cocaine abuse (United States Patent 5,821,386)
4' and 4', 4"-substituted-3-.alpha.-(diphenylmethoxy) tropane analogs as cocaine therapeutics (United States Patent 5,792,775)
Method for treating cocaine and amphetamine dependency (United States Patent 5,760,044)
Reagent for the identification of cocaine (United States Patent 5,753,513)
Cocaine receptor binding ligands (United States Patent 5,736,123)
Immunogens for the production of cocaine-hydrolyzing catalytic antibodies (United States Patent 5,730,985)
Labelling colors for detecting cocaine or methamphetamine, method of preparing the same and detector for cocaine or methamphetamine (United States Patent 5,571,727)
Cocaine analogues and their use as cocaine drug therapies and therapeutic and imaging agents for neurodegenerative disorders (United States Patent 5,506,359)
Cocaine receptor binding ligands (United States Patent 5,496,953)
Reagents for generating a polyclonal hydrolytic antibody response against cocaine and the monoclonal hydrolytic antibodies against cocaine derived through these reagents (United States Patent 5,463,028)
Cocaine esterase from Pseudomonas sp. NCIMB 40427 for detection of cocaine (United States Patent 5,462,868)
Therapeutics for management of cocaine induced toxicity (United States Patent 5,441,982)
Cocaine receptor binding ligands (United States Patent 5,413,779)
Use of delta opioid receptor antagonists to treat cocaine abuse (United States Patent 5,411,965)
Cocaine analogs (United States Patent 5,391,744)
Cocaine receptor binding ligands (United States Patent 5,380,848)
Cocaine analogs (United States Patent 5,268,480)
Cocaine derivatives (United States Patent 5,233,042)
Treatment for cocaine abuse (United States Patent 5,229,120)
Cocaine and cocaine metabolites assay tracers, immunogens and antibodies (United States Patent 5,202,270)
5-aminocarbonyl-5H-dibenzo[a.d]cyclohepten-5,10-imines for treatment of epilepsy and cocaine addiction (United States Patent 5,196,415)
Treatment of cocaine addiction (United States Patent 5,189,064)
Use of sigma receptor antagonists for treatment of cocaine abuse (United States Patent 5,180,729)
Cocaine receptor binding ligands (United States Patent 5,128,118)
Use of calcium channel blocker to prevent cocaine induced craving and reinforcement (United States Patent 5,124,340)
Treatment for cocaine use employing valproic acid (United States Patent 5,102,913)
Treatment for cocaine abuse (United States Patent 5,075,341)
Treatment for cocaine use (United States Patent 5,028,611)
Treatment for cocaine addiction (United States Patent 4,942,182)
Rapid method for interrupting the cocaine and amphetamine abuse syndrome (United States Patent 4,587,243)
Paper device for rapid detection of cocaine (United States Patent 4,320,086)
Available aroma of cocaine (United States Patent 4,260,517)
Simultaneous radio immunoassay of multiple antigens and _assay for cocaine metabolites (United States Patent 4,235,864)
Simultaneous immunoassay of multiple antigens and assay for cocaine metabolites (United States Patent 4,207,307)
Non-oxo-carbonyl containing benzoyl ecgonine and cocaine compounds and derivatives thereof (United States Patent 4,123,431)
Non-oxo-carbonyl containing benzoyl ecgonine and cocaine compounds polypeptide and derivatives thereof (United States Patent 4,045,420)
Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the same, and crack cocaine conjugates (United States Patent 7,105,643)
Cocaine receptor binding ligands (United States Patent 7,011,813)
Anti-cocaine catalytic antibody (United States Patent 6,913,917)
Analogs of cocaine (United States Patent 6,806,281)
Pramipexole as a treatment for cocaine craving (United States Patent 6,750,235)
Cocaine receptor binding ligands (United States Patent 6,706,880)
Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants (United States Patent 6,566,400)
Catalytic antibodies against cocaine and methods of using and producing same (United States Patent 6,566,084)
Cocaine receptor binding ligands (United States Patent 6,531,483)
Analogs of cocaine (United States Patent 6,472,422)
Anti-cocaine vaccine (United States Patent 6,383,490)
Methods for treating psychosis associated with cocaine addiction with glucocorticoid receptor antagonists (United States Patent 6,362,173)
Cocaine receptor binding ligands (United States Patent 6,329,520)
Anti-cocaine catalytic antibody (United States Patent 6,280,987)
Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody (United States Patent 6,271,381)
Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants (United States Patent 6,194,459)
Catalytic antibodies against cocaine and methods of using and producing same (United States Patent 6,184,013)
Analogs of cocaine (United States Patent 6,180,648)
Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody (United States Patent 6,174,723)
Process and test kit for cocaine detection (United States Patent 6,133,040)
Method for making cocaine receptor binding ligands and intermediates therefor (United States Patent 6,123,917)
Immunogens for the production of cocaine-hydrolyzing catalytic antibodies (United States Patent 6,017,541)
Catalytic antibodies against cocaine (United States Patent 5,990,285)
Catalytic antibodies against cocaine (United States Patent 5,977,314)
Anti-cocaine catalytic antibody (United States Patent 5,948,658)
Methods for controlling invertebrate pests using cocaine receptor binding ligands (United States Patent 5,935,953)
Labeled cocaine analogs (United States Patent 5,888,475)
Low dosage treatment for cocaine craving and withdrawal (United States Patent 5,869,474)
Labeled cocaine analogs (United States Patent 5,864,038)
Cocaine analogs (United States Patent 5,834,484)
Compounds for treating cocaine abuse (United States Patent 5,821,386)
4' and 4', 4"-substituted-3-.alpha.-(diphenylmethoxy) tropane analogs as cocaine therapeutics (United States Patent 5,792,775)
Method for treating cocaine and amphetamine dependency (United States Patent 5,760,044)
Reagent for the identification of cocaine (United States Patent 5,753,513)
Cocaine receptor binding ligands (United States Patent 5,736,123)
Immunogens for the production of cocaine-hydrolyzing catalytic antibodies (United States Patent 5,730,985)
Labelling colors for detecting cocaine or methamphetamine, method of preparing the same and detector for cocaine or methamphetamine (United States Patent 5,571,727)
Cocaine analogues and their use as cocaine drug therapies and therapeutic and imaging agents for neurodegenerative disorders (United States Patent 5,506,359)
Cocaine receptor binding ligands (United States Patent 5,496,953)
Reagents for generating a polyclonal hydrolytic antibody response against cocaine and the monoclonal hydrolytic antibodies against cocaine derived through these reagents (United States Patent 5,463,028)
Cocaine esterase from Pseudomonas sp. NCIMB 40427 for detection of cocaine (United States Patent 5,462,868)
Therapeutics for management of cocaine induced toxicity (United States Patent 5,441,982)
Cocaine receptor binding ligands (United States Patent 5,413,779)
Use of delta opioid receptor antagonists to treat cocaine abuse (United States Patent 5,411,965)
Cocaine analogs (United States Patent 5,391,744)
Cocaine receptor binding ligands (United States Patent 5,380,848)
Cocaine analogs (United States Patent 5,268,480)
Cocaine derivatives (United States Patent 5,233,042)
Treatment for cocaine abuse (United States Patent 5,229,120)
Cocaine and cocaine metabolites assay tracers, immunogens and antibodies (United States Patent 5,202,270)
5-aminocarbonyl-5H-dibenzo[a.d]cyclohepten-5,10-imines for treatment of epilepsy and cocaine addiction (United States Patent 5,196,415)
Treatment of cocaine addiction (United States Patent 5,189,064)
Use of sigma receptor antagonists for treatment of cocaine abuse (United States Patent 5,180,729)
Cocaine receptor binding ligands (United States Patent 5,128,118)
Use of calcium channel blocker to prevent cocaine induced craving and reinforcement (United States Patent 5,124,340)
Treatment for cocaine use employing valproic acid (United States Patent 5,102,913)
Treatment for cocaine abuse (United States Patent 5,075,341)
Treatment for cocaine use (United States Patent 5,028,611)
Treatment for cocaine addiction (United States Patent 4,942,182)
Rapid method for interrupting the cocaine and amphetamine abuse syndrome (United States Patent 4,587,243)
Paper device for rapid detection of cocaine (United States Patent 4,320,086)
Available aroma of cocaine (United States Patent 4,260,517)
Simultaneous radio immunoassay of multiple antigens and _assay for cocaine metabolites (United States Patent 4,235,864)
Simultaneous immunoassay of multiple antigens and assay for cocaine metabolites (United States Patent 4,207,307)
Non-oxo-carbonyl containing benzoyl ecgonine and cocaine compounds and derivatives thereof (United States Patent 4,123,431)
Non-oxo-carbonyl containing benzoyl ecgonine and cocaine compounds polypeptide and derivatives thereof (United States Patent 4,045,420)
Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the same, and crack cocaine conjugates (United States Patent 7,105,643)
Cocaine receptor binding ligands (United States Patent 7,011,813)

Although his recognition as a registered patent agent permits him to represent others in all patent matters before the United States Patent and Trademark Office, Dr. Demchick limits his practice to patent matters involving inventions for which he is confident that his expertise will allow him to serve his client well. He will gladly discuss whether he is comfortable handling cases involving inventions in a particular field. He will err on the side of declining cases if he has uncertainty about his ability to do what is needed in the case. Dr. Demchick does not represent clients in court. However, he refers clients to a patent attorney who does represent others in court, if it appears likely that patent related representation in court is appropriate. Dr. Demchick prepares and files non-provisional (regular) patent applications and provisional patent applications. He prepares and files utility patent applications and design patent applications. He prepares and files U.S. patent applications and international patent applications under the Patent Cooperation Treaty (PCT). He prepares and files applications to enter the U.S. National Phase for inventions for which international patent applications (PCT) were already filed. One of the matters he discusses with each client or potential client is which type of application(s) best meets that client's needs. He usually does a patent search (patentability search) as part of the preparation of a patent application. He discusses the value of patent searching with each inventor before agreeing to prepare a patent application for that inventor.